m6A methylases that participate in cancer glycolytic metabolic pathways
m6A methylases that participate in cancer glycolytic metabolic pathways. Cancer cells rely on glycolytic pathways to meet their energy needs for growth and proliferation, and m6A-associated enzymes participate in the cancer glycolytic pathway. The m6A methyltransferase METTL3 is able to promote glycolysis and tumor progression through m6A modification-mediated downstream targets (PDK4, GLUT1, HK2, GLUT1, GLUT4 and ENO2). METTL14 inhibits glycolysis and tumor progression by accelerating the degradation of BPTF mRNA. WTAP is able to mediate the glycolytic process of tumors and promote tumor progression through either upregulating ENO1 expression or enhancing the stability of HK2 mRNA in an m6A-dependent manner. ALKBH5 has a dual effect on the glycolytic pathway, on one hand attenuating CK2α, and on the other hand increasing the stability of GLUT4 mRNA, thereby promoting the glycolysis of breast cancer cells. FTO inhibits glycolysis and thyroid cancer growth by reducing the stability of apoE mRNA in an m6A-dependent manner. Finally, YTHDF1 enhances glycolysis by improving the protein translation of PKM2, thereby promoting the progression of breast cancer. apoE, apolipoprotein E; METTL3/4, methyltransferase-like 3/4; WTAP, Wilms tumor 1-associated protein; FTO, fat mass and obesity-associated protein; ALKBH5, α-ketoglutarate-dependent dioxygenase homolog 5; PDK4, pyruvate dehydrogenase kinase 4; GLUT1/4, glucose transporter 1/4; YTHDF1/2/3, YTH domain family protein 1/2/3; HK2, hexokinase 2; ENO2, enolase 2; BPTF, bromodomain PHD finger transcription factor; CK2α, casein kinase 2α; m6A, N6-methyladenosine; PKM2, pyruvate kinase M2; ENO2, enolase 2
Publication
Mechanisms of N6-methyladenosine modification in tumor development and potential therapeutic strategies (Review) (2023) Xi Pu, et al. Int J Oncol. 2023 Jun;62(6). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PDK4 | PDK4 | ncbigene_symbol | PDK4 | 5166 |
| Homo sapiens | Primates | METTL3 | METTL3 | ncbigene_symbol | METTL3 | 56339 |
| Homo sapiens | Primates | METTL14 | METTL14 | ncbigene_symbol | METTL14 | 57721 |
| Homo sapiens | Primates | GLUT4 | GLUT4 | ncbigene_synonym | SLC2A4 | 6517 |
| Homo sapiens | Primates | ENO2 | ENO2 | ncbigene_symbol | ENO2 | 2026 |
| Homo sapiens | Primates | GLUT1 | GLUT1 | ncbigene_synonym | SLC2A1 | 6513 |
| Homo sapiens | Primates | HK2 | HK2 | ncbigene_symbol | HK2 | 3099 |
| Homo sapiens | Primates | HK2 | HK2 | ncbigene_synonym | KCNA5 | 3741 |
| Homo sapiens | Primates | HK2 | HK2 | ncbigene_synonym | KIF2A | 3796 |
| Homo sapiens | Primates | HK2 | HK2 | ncbigene_synonym | KLK2 | 3817 |
| Homo sapiens | Primates | HK2 | HK2 | ncbigene_synonym | HOOK2 | 29911 |
| Homo sapiens | Primates | WTAP | WTAP | ncbigene_symbol | WTAP | 9589 |
| Homo sapiens | Primates | ΕΝΟΙ | ENO | famplex_relations | ENO1 | 2023 |
| Homo sapiens | Primates | ΕΝΟΙ | ENO | famplex_relations | ENO3 | 2027 |
| Homo sapiens | Primates | ΕΝΟΙ | ENO | famplex_relations | ENO4 | 387712 |
| Homo sapiens | Primates | BPTF | BPTF | ncbigene_symbol | BPTF | 2186 |
| Homo sapiens | Primates | ALKBH5 | ALKBH5 | ncbigene_symbol | ALKBH5 | 54890 |
| Homo sapiens | Primates | FTO | FTO | ncbigene_symbol | FTO | 79068 |
| Homo sapiens | Primates | PKM2 | PKM2 | ncbigene_synonym | PKM | 5315 |
| Homo sapiens | Primates | PKM2 | PKM2 | famplex_relations | PKLR | 5313 |
| Homo sapiens | Primates | YTHDF1 | YTHDF1 | ncbigene_symbol | YTHDF1 | 54915 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| thyroid | Thyroid | chebi:9584 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| cancer | cancer | cancer | DOID:162 | |
| cancer | cancer | cancer | DOID:162 | |
| carcinoma | carcinoma | carcinoma | DOID:305 | |
| cancer | cancer | cancer | DOID:162 | |
| cancer | cancer | cancer | DOID:162 | |
| cancer | cancer | cancer | DOID:162 | |
| carcinoma | carcinoma | carcinoma | DOID:305 | |
| cancer | cancer | cancer | DOID:162 | |
| cancer | cancer | cancer | DOID:162 | |
| carcinoma | carcinoma | carcinoma | DOID:305 | |
| cancer | cancer | cancer | DOID:162 | |
| Breast cancer | breast cancer | breast cancer | DOID:1612 | |
| Colorectal cancer | colorectal cancer | colorectal cancer | DOID:9256 | |
| Breast cancer | breast cancer | breast cancer | DOID:1612 | |
| Papillary carcinoma | papillary carcinoma | papillary carcinoma | DOID:3113 | |
| Renal cell carcinoma | renal cell carcinoma | renal cell carcinoma | DOID:4450 |